Sesame Summit 2026 – application open

Top 10 Healthcare Events and Conferences in 2021 – Selected

If 2020 taught us nothing else it’s that health matters. From stress relief to cognitive function, exercise and a healthy lifestyle had previously proven difficult for most to achieve due to a simple lack of time. Or perceived lack of time.

A global pandemic has changed all of that. And in so much, the Healthcare industry is set to explode in the coming years. If you want in, and you know you do, here are our Top 10 picks for Healthcare Events and Conferences coming up in the first quarter of 2021.

Did we miss some? Let us know about it!

smrs.link/add-event


Top healthcare conferences in January

blank

CES 2021

January 11-14, Virtual Event

#tradeshow #digital #health #wellness #fitness #technology #wearables

CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50+ years – the global stage where next-generation innovations are introduced to the marketplace.

Health is a key focus and the digital health summit is a track within the larger conference.

Biotech Showcase 2021

January 11-15, Virtual Event

#conference #biotech #medtech #digital #medicine #pharmaceutical #investors

Biotech Showcase Digital is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives.

This year’s edition offers a seed showcase for startups to present their solutions and meet investors.

Top healthcare conferences in February

blank

HETT Reset 2021

February 8-12, Virtual Event

#conference #healthtech #innovation #digital #health #ecosystem

HETT Reset will reconnect the healthtech and digital health ecosystem at a critical time, with healthcare organisations seeking to lock in the gains and progress made by the sudden and unprecedented transformation in the use of digital health services in response to COVID-19.

From case studies and panel discussions to workshops and live Q&As, the event will cover topics critical to the successful adoption and integration of technology in all healthcare settings across 5-focused days of content and networking opportunities.

Scope Summit 2021

February 2-4, Virtual Event

#conference #clinical #trials #digital #health #data #medical #devices

SCOPE Summit 2021 takes place as a fully virtual event. The program focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations.

This year’s edition covers 12 conference tracks.

DTx West 2021

February 23-25, Virtual Event

#conference #telemedicine #digital #therapeutics #pharmaceutical

DTx West is going virtual. Working with industry leaders, the event provides even more high-quality learning and networking opportunities than usual, through a truly interactive virtual experience. With the recent changes in healthcare, it is now more crucial than ever to accelerate digital therapeutics into the hands of patients.

Top healthcare conferences in March

blank

SXSW 2021

March 16-20, Virtual Event

#festival #creative #health #medtech #DeepTech #innovation

SXSW celebrates the convergence of the interactive, film, and music industries. The conference provides an opportunity for global professionals at every level to participate, network, and advance their careers.

SXSW Health and MedTech Expo is the sub-event of the famed SXSW music, interactive, and film festival.

DIA Europe 2021

March 15-19, Virtual Event

#conference #telemedicine #digital #health  #pharmaceutical #ecosystem

DIA Europe 2021 brings together thousands of innovators from around the globe. It is the must-attend event for all life science professionals working in drug development, from discovery to marketed use.

Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need for your everyday job, your participation will accelerate your growth and your organization’s performance in the development ecosystem.

The Festival of Biologics 2021

March 29 – April 2, Virtual Event

#festival #biologics #pharma #biotech #antibody #innovation

The Festival of Biologics brings together industry leaders from across antibodies, immunotherapy and biosimilars.

There are two parts to the Festival of Biologics: three events covering America Antibody Congress, World Immunotherapy Congress, World Biosimilars Congress and an exhibition featuring solutions for pharma and biotech.

WIRED Health

March 31, London, UK

#conference #healthtech #innovation #DeepTech

WIRED Health explores and maps the future of health, highlighting the thought-provoking disruptors, scientists and practitioners paving paths in how we access, provide and improve patient care.

Since its launch in 2014, WIRED Health continues to connect innovators with influencers and to inspire business decision-makers, entrepreneurs and medical professionals with its editorially-curated programme and interactive Test Lab.

you might also like

Fundraising 11 minutes ago

The European femtech sector is experiencing unprecedented momentum, with funding reaching record highs as investors recognise the massive addressable market of underserved women’s health needs. Bristol-based Emm exemplifies this trend, having secured €7.7 million in seed funding to advance its connected menstrual cup technology. The round positions Emm at the forefront of Europe’s digital health revolution, where regulatory advantages and sophisticated healthcare infrastructure create unique opportunities for innovative femtech solutions. Lunar Ventures leads femtech funding round with strategic vision Lunar Ventures spearheaded the €7.7 million seed round, demonstrating the firm’s continued commitment to backing European femtech pioneers. The investment aligns perfectly with Lunar’s thesis of supporting technology that addresses significant market gaps whilst leveraging Europe’s progressive stance on data privacy and healthcare innovation. “Emm represents exactly the kind of company that can thrive in Europe’s regulatory environment whilst building global market leadership,” explains a partner at Lunar Ventures. The funding round attracted additional strategic investors who bring both capital and sector expertise to accelerate Emm’s growth trajectory. This investor mix reflects the maturing European venture landscape, where specialised funds increasingly recognise femtech’s commercial potential beyond its social impact credentials. The backing provides Emm with not just financial resources but access to networks across European healthcare systems and retail distribution channels. Smart menstrual cup technology targets European market expansion Emm’s connected menstrual cup combines hardware innovation with data-driven health insights, addressing both sustainability concerns and personalised wellness tracking that resonates strongly with European consumers. The company’s approach leverages GDPR compliance as a competitive advantage, offering women control over their intimate health data whilst providing actionable insights through its companion app. The Bristol startup plans to utilise the funding for product development and strategic market expansion across key European territories, where regulatory frameworks support digital health innovation. “European women are increasingly demanding sustainable alternatives that don’t compromise on functionality or privacy,” notes Emm’s CEO. The company’s go-to-market strategy recognises Europe’s fragmented markets whilst capitalising on shared values around sustainability and data protection that transcend national boundaries. Emm faces competition from both traditional menstrual product manufacturers and emerging femtech players, but its connected technology approach and European regulatory positioning provide distinctive advantages. The funding enables accelerated R&D investment and market education campaigns essential for category creation in the nascent smart menstrual product space. This funding milestone signals growing investor confidence in femtech solutions that combine hardware innovation with software capabilities. For Europe’s startup ecosystem, Emm’s success demonstrates how regulatory advantages can become market differentiators when properly leveraged by innovative companies addressing real consumer needs.

Fundraising 18 hours ago

As digital fraud losses surge past €4.2 billion annually across Europe, the continent’s identity verification sector is attracting unprecedented investor attention. Romanian fraud prevention specialist TMT ID has secured €34 million in growth funding from BGF, marking one of the largest fraud prevention investments in Eastern Europe this year. The Bucharest-based company, which provides AI-powered identity verification and fraud detection solutions, will use the capital to accelerate expansion across European markets whilst bolstering its technology platform to address the continent’s mounting digital trust challenges. BGF backs fraud prevention technology amid rising digital threats Business Growth Fund’s investment in TMT ID reflects growing institutional confidence in European fraud prevention technologies. The London-based growth capital firm, which typically invests £2-10 million in scaling businesses, sees significant opportunity in the identity verification sector as regulatory pressure intensifies across EU markets. “The fraud prevention market in Europe is experiencing a perfect storm of regulatory demand and technological innovation,” said a BGF spokesperson regarding the investment. “TMT ID’s proven track record in complex markets like Romania positions them uniquely for pan-European expansion.” BGF’s investment thesis centres on TMT ID’s proprietary AI algorithms, which can process over 100,000 identity verifications per hour whilst maintaining compliance with GDPR and emerging AI Act requirements. This technical capability becomes crucial as European financial services face stricter KYC obligations under the upcoming AML6 directive. The funding round positions TMT ID alongside other European fraud prevention unicorns like London’s Onfido and Berlin’s IDnow, both of which have secured significant US investment despite their European origins. Romanian fintech eyes Western European expansion strategy TMT ID’s expansion strategy focuses on Germany, France, and the Netherlands, where fraud losses have increased 23% year-on-year according to European Central Bank data. The company’s technology currently processes over 2 million identity checks monthly for Romanian banks and telecommunications companies. “We’re seeing massive demand from Western European enterprises who need fraud prevention solutions that understand both local regulations and cross-border criminal patterns,” explained TMT ID CEO regarding the company’s growth trajectory. The Romanian company differentiates itself through multi-language support and deep understanding of Eastern European fraud patterns, which increasingly impact Western markets as criminal networks become more sophisticated. This regional expertise proves valuable as European banks struggle with cross-border fraud detection. TMT ID’s client roster includes major Romanian financial institutions and telecommunications providers, with the company reporting 150% revenue growth over the past 18 months. The fresh capital will fund technology development, regulatory compliance infrastructure, and strategic hires across key European markets. This investment signals broader confidence in Eastern European fintech capabilities, following similar growth rounds for Polish payment processor PayU and Czech Republic’s Bohemia Interactive. European fraud prevention remains a strategic priority as digital transformation accelerates across traditional industries.

Fundraising 19 hours ago

Europe’s defence technology sector is experiencing unprecedented momentum as geopolitical tensions reshape investment priorities across the continent. Traditional venture capital firms are pivoting towards dual-use technologies, whilst specialised funds emerge to capitalise on the estimated €500 billion European defence modernisation market over the next decade. London-based Keen Venture Partners has secured €150 million for what it claims is Europe’s largest dedicated DefenceTech fund, marking a significant milestone in the maturation of European military technology investment. The fund received backing from the European Investment Fund alongside several undisclosed institutional investors, positioning Keen as a major player in the rapidly expanding sector. DefenceTech fund raising reflects strategic European priorities The European Investment Fund’s participation signals institutional recognition of defence technology as a strategic priority for European autonomy. Unlike traditional Silicon Valley defence investors focused on large-scale contracts, Keen’s thesis centres on dual-use technologies that serve both civilian and military applications—a distinctly European approach that navigates complex regulatory frameworks whilst maximising commercial potential. “Modern battlefield requirements are evolving faster than traditional defence procurement cycles can accommodate,” explains the investment team. “We’re backing founders who understand that today’s conflicts demand software-first solutions, autonomous systems, and cyber resilience capabilities that can be deployed rapidly across multiple domains.” This €150 million represents more than double the typical European defence-focused fund, reflecting both increased LP appetite and the scale of opportunities emerging across the continent. The fund’s structure accommodates longer development cycles typical of defence applications whilst maintaining the growth trajectory expectations of institutional investors. European DefenceTech ecosystem gains institutional momentum Keen’s strategy targets startups developing autonomous systems, cybersecurity infrastructure, satellite communications, and advanced materials—sectors where European companies increasingly compete with established US and Israeli defence contractors. The fund’s European focus addresses a critical gap in defence technology financing, where American investors often require US-centric business models that limit European market penetration. The timing proves strategic as NATO’s Defence Innovation Accelerator ramps up activity and member states increase defence spending commitments to 2% of GDP. European governments are actively seeking indigenous alternatives to reduce dependence on non-EU defence suppliers, creating substantial market opportunities for portfolio companies that can navigate complex certification processes. Portfolio construction will emphasise companies with proven dual-use applications, regulatory compliance expertise, and scalable technologies adaptable to different European markets. This approach differentiates Keen from generalist VCs attempting to add defence exposure through occasional investments in the sector. This fund launch reinforces Europe’s emergence as a serious player in defence technology innovation, moving beyond traditional aerospace and shipbuilding towards the software-defined capabilities that will determine future military effectiveness. For European defence startups, access to dedicated capital with sector expertise removes a significant barrier to scaling within the continent’s complex regulatory and procurement environment.

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.